Axitinib Related Compounds & Impurities

Axitinib is a selective VEGF receptor 1-3 inhibitor that suppresses tumour angiogenesis, used for advanced renal cell carcinoma.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Axitinib reference standards, pharmacopeial and non-pharmacopeial Axitinib impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Axitinib-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Axitinib
(Z)-Axitinib
Axitinib impurity A
Axitinib EP Impurity B
Axitinib EP Impurity C
Axitinib EP Impurity D
Axitinib Impurity F
Axitinib EP Impurity H
Axitinib Impurity 31
Axitinib Impurity 4
N-Methyl-2-((3-(2-(pyridin-2-yl)ethyl)-1H-indazol-6-yl)thio)benzamide
Axitinib Acid
Axitinib Dimer
Axitinib Sulfoxide
Axitinib Sulfone
Axitinib Lactose Adduct
Axitinib Galactose Adduct
Axitinib N-Methyl Impurity
Axitinib Impurity 1
N-Methyl-2-[[3-[(1E)-2-(oxidopyridinyl) ethenyl]-1H-indazol-6-yl]-thiol]-benzamide
N-Methyl-2-[[3-[(1E)-2-(1-oxopyridinyl)ethenyl]-1-oxido-1H-indazol-6-y-sulfinyl]]benzamide
Axitinib Impurity 5
Axitinib Impurity 3
Axitinib-D3 Hydrate
Axitinib Impurity 12
Axitinib Impurity 14
Axitinib Dimer Impurity 2
Axitinib Thio Benzamide Impurity
N-methyl-2-((6`-(2-(methylcarbamoyl)benzyl)-1H,1`H-[3,3`-biindazol]-6-yl)thio)benzamide
Axitinib N-Formyl Impurity
Axitinib N b glucuronide
Axitinib Impurity 20
Axitinib N-Oxide
Axitinib N-Glucuronide (M7)
Axitinib Impurity 9
Axitinib Form IV
Axitinib Form SAB-1
Axitinib Impurity H
Axitinib N-Oxide
N-Nitroso Axitinib
Axitinib Nitroso Impurity 2
Axitinib Nitroso Impurity 3
Axitinib Nitroso Impurity 4
Axitinib Impurity 26
6-Iodo-1H-indazole
Axitinib Impurity 7
Axitinib Impurity 6
Axitinib Impurity 10
Axitinib Impurity 11
Axitinib Impurity 13

Isotope Labelled Compounds

Axitinib -13C-D3